For the Inventor, By the Inventor

Enter assignee name

West Conshohocken, PA, United States of America

Madrigal Pharmaceuticals, Inc.

USPTO Granted Patents = 28

% Expired Patents = 35.7

EPO Patents = 10

Trademarks = 2

Forward Citations = 69

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

Weiwen Ying (9 out of 64 patents)

Dinesh U Chimmanamada (9 out of 46 patents)

Rebecca Taub (9 out of 11 patents)

4. Yimin Qian (6 out of 73 patents)

5. David Robert Bolin (6 out of 22 patents)

6. Ping Wang (4 out of 34 patents)

7. Lianhe Shu (4 out of 6 patents)

8. Duk Soon Choi (4 out of 4 patents)

9. Adrian Wai-Hing Cheung (4 out of 15 patents)

10. Martha Jean Kelly (4 out of 17 patents)

11. Robert J Duguid (3 out of 12 patents)

12. D Keith Hester, Ii (3 out of 4 patents)

13. Anna Chasnoff (3 out of 3 patents)

14. Gang Dong (3 out of 3 patents)

15. Edwin L Crow (3 out of 3 patents)

Core Competencies:

Fatty Liver Disease

Liver Disorders

Rosuvastatin

Resmetirom

THR-Beta Agonist

Combination Therapies

Targeted Therapeutics

Cytokine Production

Diacylglycerol Acyltransferase

Thyroid Hormone Analogs

Polymorphs

Inhibitors

28 patents: Sort by Forward Citations

1. 12667575 - Methods for treating a fatty liver disease (2026-06-30),

2. 12661361 - Resmetirom for reducing liver volume (2026-06-23),

3. 12661359 - Therapeutic combinations of rosuvastatin and resmetirom for the treatment of liver disorders or lipid disorders (2026-06-23),

4. 12377104 - Methods for treating a fatty liver disease (2025-08-05),

5. 11986481 - Method of synthesizing thyroid hormone analogs and polymorphs thereof (2024-05-21),

6. 11806353 - Methods of treating liver disorders or lipid disorders with a THR-beta agonist (2023-11-07),

7. 11564926 - Methods of synthesizing thyroid hormone analogs and polymorphs thereof (2023-01-31),

8. 11491145 - Combination therapies comprising targeted therapeutics (2022-11-08),

9. 11377447 - Targeted therapeutics (2022-07-05),

10. 11090308 - Methods of treating liver disorders or lipid disorders with a THR-beta agonist (2021-08-17),

11. 10894050 - Methods of synthesizing thyroid hormone analogs and polymorphs thereof (2021-01-19),

12. 10828315 - Targeted therapeutics (2020-11-10),

13. 10722525 - Targeted therapeutics (2020-07-28),

14. 10675360 - Targeted therapeutics (2020-06-09),

15. 10376598 - Targeted therapeutics (2019-08-13),

Company Overview

Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company based in West Conshohocken, Pennsylvania, focused on developing innovative therapies for liver and metabolic diseases. The company specializes in advancing treatments that target specific pathways involved in these conditions, with a strong emphasis on research and clinical development. Madrigal aims to address significant unmet medical needs through its proprietary drug candidates, leveraging cutting-edge science to improve patient outcomes in the field of metabolic health.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

28 Patents

#2 in West Conshohocken, PA

#438 in Pennsylvania

#12,013 in US

#23,285 in the World

West Conshohocken, PA, United States of America

Madrigal Pharmaceuticals, Inc.

Forward Citations = 69

40 inventors:

Weiwen Ying (9 out of 64 patents)

Dinesh U Chimmanamada (9 out of 46 patents)

Rebecca Taub (9 out of 11 patents)

4. Yimin Qian (6 out of 73 patents)

5. David Robert Bolin (6 out of 22 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Madrigal Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/madrigal-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…